Wyeth Receives FDA Approval Of Protonix For Delayed Release Oral Suspension
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that the U.S. Food and Drug Administration (FDA) has approved Protonix® (pantoprazole sodium) For Delayed-Release Oral Suspension, a new addition to the Protonix family of prescription medications. [click link for full article]
More: continued here